JPS63250316A - Bathing agent - Google Patents
Bathing agentInfo
- Publication number
- JPS63250316A JPS63250316A JP8551387A JP8551387A JPS63250316A JP S63250316 A JPS63250316 A JP S63250316A JP 8551387 A JP8551387 A JP 8551387A JP 8551387 A JP8551387 A JP 8551387A JP S63250316 A JPS63250316 A JP S63250316A
- Authority
- JP
- Japan
- Prior art keywords
- bath
- tablet
- carbonate
- bathtub
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003287 bathing Methods 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 4
- 238000010521 absorption reaction Methods 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims abstract description 3
- 150000001342 alkaline earth metals Chemical class 0.000 claims abstract description 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 239000003112 inhibitor Substances 0.000 claims abstract description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 2
- -1 sesquicarbonates Chemical class 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 31
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract description 4
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 3
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 108010010803 Gelatin Proteins 0.000 abstract description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract description 2
- 239000011230 binding agent Substances 0.000 abstract description 2
- 229920000159 gelatin Polymers 0.000 abstract description 2
- 239000008273 gelatin Substances 0.000 abstract description 2
- 235000019322 gelatine Nutrition 0.000 abstract description 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 2
- 229940071207 sesquicarbonate Drugs 0.000 abstract 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 abstract 1
- 235000011089 carbon dioxide Nutrition 0.000 abstract 1
- 229920006184 cellulose methylcellulose Polymers 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 22
- 229910002092 carbon dioxide Inorganic materials 0.000 description 15
- 239000007789 gas Substances 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 239000001569 carbon dioxide Substances 0.000 description 12
- 238000005187 foaming Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 7
- 238000002845 discoloration Methods 0.000 description 7
- 150000007524 organic acids Chemical class 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000013040 bath agent Substances 0.000 description 3
- 239000003788 bath preparation Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 239000004484 Briquette Substances 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000540506 Aroga Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010064031 Limb crushing injury Diseases 0.000 description 1
- 241000219470 Mirabilis Species 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000490025 Schefflera digitata Species 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004574 high-performance concrete Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 229940016373 potassium polysulfide Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は浴場に投入すると、炭酸ガス泡を発生しつ\溶
解し、その炭酸ガスならびに溶解成分が浴用有効成分と
しての効能を発揮する浴用剤に関するものである。Detailed Description of the Invention (Industrial Application Field) The present invention is a bath-use product that generates and dissolves carbon dioxide gas bubbles when added to a bath, and the carbon dioxide gas and dissolved components exert the effect as an active ingredient for baths. This is related to drugs.
温泉の効能効果は同大の認めるところであり、その構成
々分によって各対応症が決められる。The university recognizes the effectiveness of hot springs, and the corresponding symptoms are determined by the components of the hot springs.
天然温泉は大別して(単純泉)1食塩泉、芒硝泉。Natural hot springs can be roughly divided into (simple springs), salt springs, and mirabilis springs.
アルカリ泉1石膏泉、苦土泉、明容泉、鉄泉、硫黄泉、
炭酸泉(ラジウム泉)があり、含有成分はNt;、に−
、Ca″:Mi、P;’、 CI’、8r’、SO’、
’、PO;’、 JIBOj、”、 HCO’、、H5
:SiO’z等の無機イオン(伺が含まれており、この
組合わせ配合により浴用剤が市販されている。人工浴用
剤にはその他、ソウジュッ、カノコソウ9カミツレ、ニ
ンジン、ケイヒ、ウィキョウ、チンピ等の生薬成分(ロ
)、サリチル酸メチル、メントール、テレピン油等の香
料成分(ハ)、大豆油。Alkaline springs 1 gypsum spring, bitter earth spring, meyo spring, iron spring, sulfur spring,
There is a carbonated spring (radium spring), and the content is Nt;
, Ca″:Mi, P;′, CI′, 8r′, SO′,
',PO;',JIBOj,',HCO',,H5
:Contains inorganic ions such as SiO'z, and bath preparations are commercially available with this combination.Other artificial bath preparations include soju, valerian, ginseng, cinnamon bark, fennel, chimpi, etc. herbal medicine ingredients (b), flavoring ingredients such as methyl salicylate, menthol, turpentine oil (c), and soybean oil.
米ヌカ油、流動パラフィン、スクヮラン、レシチン等の
油性成分(ニ)、カリ石鹸、界面活性剤。Oily ingredients (d) such as rice bran oil, liquid paraffin, squalane, and lecithin, potash soap, and surfactants.
酵素等の除汚成分(ホ)、卵黄未、脱脂粉乳、ビタミン
等の栄養成分(へ)、色素、白土、炭酸マグネシウム、
マイカ粉等の着色着濁成分(ト)も有効とされている。Decontamination ingredients such as enzymes (e), egg yolk, skim milk powder, nutritional ingredients such as vitamins (e), pigments, clay, magnesium carbonate,
Colored and cloudy ingredients (g) such as mica powder are also said to be effective.
(従来の技術)
前記の有効成分(イ)〜(ト)の配合浴用剤は夫々の薬
効効果は認められるとしても、天然の温泉をその侭再現
し得るものでもないが、なるべく近似する如く研究され
ている。その一つに炭酸泉があり、飲料は別として神経
症、皮膚アレルギーに対して効能があることが明らかに
されており、++co/3.co;の溶存イオンのみで
なくCO□の発泡現象も重要な因子であるとされている
。(Prior art) Although the bath preparations containing the above-mentioned active ingredients (a) to (g) have respective medicinal effects, they cannot reproduce the natural hot springs as they were, but research efforts are being made to approximate them as much as possible. has been done. One of them is carbonated springs, which, apart from drinking, have been shown to be effective against neurosis and skin allergies, and ++co/3. It is said that not only the dissolved ions of CO; but also the foaming phenomenon of CO□ are important factors.
この発泡タイプについて、■炭酸ナトリウム。About this foaming type: ■Sodium carbonate.
重炭酸ナトリウムを炭酸源として之に酒石酸・コハク酸
・フマル酸等の有機酸を配合したもの、■リン酸・リン
酸水素ナトリウムを配合したもの、■炭酸ナトリウムと
硫酸ナトリウムの複塩と有機酸の配合になるものが公知
である。また■コハク酸と重炭酸ナトリウムとの配合に
よるブリケット状品が市販されている。■Contains organic acids such as tartaric acid, succinic acid, and fumaric acid using sodium bicarbonate as the carbonate source; ■Contains phosphoric acid and sodium hydrogen phosphate; ■Double salt of sodium carbonate and sodium sulfate and organic acids. It is known that the composition is as follows. Also, briquette-like products made from a combination of succinic acid and sodium bicarbonate are commercially available.
(発明が解決しようする問題点)
前記の従来技術の炭酸水素ナトリウムとコハク酸配合物
においては、CO□を発生するための酸物質は有機酸で
ある。他に酒石酸、クエン酸、リンゴ酸、アジピン酸等
固形有機酸が用い得るとしても、2等有機酸は前記(イ
)〜(ト)の有効成分として認められないもの、即ち無
駄な成分でありかつそれらは割合に高価である。(Problems to be Solved by the Invention) In the prior art sodium bicarbonate and succinic acid combinations described above, the acid substance for generating CO□ is an organic acid. Even if other solid organic acids such as tartaric acid, citric acid, malic acid, and adipic acid can be used, secondary organic acids are not recognized as active ingredients in (a) to (g) above, that is, they are useless ingredients. And they are relatively expensive.
またブリケットタイプについてみるに、市販品は大型で
あり之が浴場中に投入すると最初は沈降して盛んに発泡
するが、やがては浴湯上面に浮きCO2の発泡効果が認
められなくなること、ならびにその持続時間が80g品
でも5分以内と短いことが欠点としてあげられる。Regarding the briquette type, commercially available products are large and when put into a bath, they initially settle and foam vigorously, but eventually they float to the top of the bath water and the foaming effect of CO2 is no longer observed. The drawback is that the duration is short, less than 5 minutes even for an 80g product.
更に重要なことは炭酸アルカリ類と酸類との混合製剤に
おいて、当然反応の起ることは予想され、これが保存中
に経時的に劣化することである。この反応は水分の存在
で起るので吸湿性の少い薬品を選択すべきであり、例え
ば公知の前記有機酸でも吸湿性の改善されたアジピン酸
を代用する提案もある。What is more important is that in mixed preparations of alkali carbonates and acids, it is naturally expected that reactions will occur, and this will deteriorate over time during storage. Since this reaction occurs in the presence of moisture, a chemical with low hygroscopicity should be selected. For example, there is a proposal to substitute adipic acid, which has improved hygroscopicity among the known organic acids mentioned above.
(問題を解決する方法ならびに作用)
本発明はアルカリ金属またはアルカリ土類金属の炭酸塩
、セスキ炭酸塩2重炭酸塩の一種または二種以上と、リ
ン酸二水素カリウム(KIlzPO4)とを主成分とし
、更に必要なときは他の浴用成分ならびに賦型剤、吸湿
防止剤、香料2色素等を配合し、その配合物を1個1.
0g以上のタブレフトに成型し、その1gを100m・
lの水に溶解した時のPRが4.5〜8.0であること
を特徴とするものである。(Method for Solving the Problems and Effects) The present invention comprises one or more carbonates of alkali metals or alkaline earth metals, sesquicarbonates, bicarbonates, and potassium dihydrogen phosphate (KIlzPO4) as main components. Then, when necessary, other bath ingredients, excipients, moisture absorption inhibitors, fragrances, 2 pigments, etc. are added, and the mixture is made into 1.
Molded into a tab left of 0g or more, 1g of it is 100m・
It is characterized by a PR of 4.5 to 8.0 when dissolved in 1 liter of water.
本発明の炭酸ガス発生機構は、例えば重曹の例をとると
NaHCOx+にHzPOa=NaKIIPOs +
HtO+COt −−−−−(1)であり、こ−で生
成したNa’に@ P O4,///ならびにC(hは
浴用有効成分である。The carbon dioxide gas generation mechanism of the present invention, taking baking soda as an example, converts NaHCOx+ into HzPOa=NaKIIPOs+
HtO+COt---(1), and the Na' produced by this is combined with @PO4, /// and C (h is an active ingredient for bathing).
浴場中より発生するC(hは人体の皮膚、特に毛穴付近
に付着し、新陳代謝機能を促すとされている。また泡が
破れる際に発生する超音波が美容効果をもたらすとの説
の真偽は別として、確かに入浴中の発泡現象は気分爽快
になるものである。而うして、−触に家庭用浴用剤を考
えるとき、家庭用浴槽は160〜200aであり。これ
に投入する浴用剤量は一成分25gと慣習的基準を厚生
省が内規設定している。そうすると、この程度の量を投
入しても濃度的に炭酸ガスは浴場に吸収され発泡はみら
れないのである。即ち単なる粉末の配合品を投入しても
CO□の発泡は瞬間的で持続セず入浴間に作用しない。It is said that C(h) generated in baths adheres to the skin of the human body, especially near the pores, and promotes metabolic function.Also, the truth or falsity of the theory that the ultrasonic waves generated when bubbles burst have a beauty effect. Apart from this, the foaming phenomenon during bathing is certainly refreshing.Thus, when we think about household bath products, home bathtubs are 160~200A. The Ministry of Health and Welfare has set a customary standard for the amount of the agent at 25g per ingredient.This means that even if this amount is injected, the carbon dioxide gas will be absorbed into the bathtub in a concentrated manner and no foaming will occur. Even if a powdered product is added, the foaming of CO□ is instantaneous and does not last long and does not work during bathing.
従って両方の薬剤濃度を局部的に高くする必要がある。Therefore, it is necessary to locally increase the concentration of both drugs.
このために、本発明では配合品をプレス打錠し、タブレ
ット型とした。この成形化のために必要に応じ界面活性
剤、ポリエチレングリコール、 CMC。For this purpose, in the present invention, the blended product was press-tableted into a tablet shape. Surfactants, polyethylene glycol, and CMC are used as necessary for this molding.
HPC,ゼラチン、デンプン等の賦形剤、結合剤、崩壊
剤、滑沢剤等を添加することができる。タブレットは水
分が存在すると(1)の反応を起こす故に、製剤時およ
び保存時はこの点留意されなければならない。浴場中に
投入するときはCO2ガスを発生しつ\タブレットは溶
解する。但しこの時奇妙なことにタブレットがあまりに
小さいと発生するCO□が錠剤を包み比重が軽くなり、
浴場表面へ浮上する。この現象は入浴時に精神安定作用
を妨害し好ましくないのでタブレットは浴槽底に沈むべ
きである。この条件は錠剤の大きさが影響するので10
kg/ca+”の同圧で成型した錠剤について実験を行
った。Excipients such as HPC, gelatin, starch, binders, disintegrants, lubricants, etc. can be added. Since tablets undergo the reaction (1) in the presence of moisture, this must be kept in mind during formulation and storage. When placed in a bath, CO2 gas is generated and the tablet dissolves. However, at this time, strangely, if the tablet is too small, the CO□ generated wraps around the tablet, reducing its specific gravity.
It floats to the surface of the bath. Since this phenomenon is undesirable as it interferes with the tranquilizing effect during bathing, the tablet should sink to the bottom of the bathtub. This condition is affected by the size of the tablet, so
An experiment was conducted on tablets molded at the same pressure of 100 kg/ca+''.
供試品配合は次の通り。(wtχ)
本発明品: Na)IcO:+ 37.4. KHzP
Ot 60.6.賦型剤2.0従来品■: NaHCO
z 42.0. NaHzPOa 56.0.賦型剤2
.0従来品■: Na1lCO356,7,コハク酸
41.3.賦型剤2.0従来晶■: Na1CO326
,O+ NazSOa 35.0酒石酸37.O賦型
剤 2.0
表1
表中の記号A:表面に浮上する。The sample composition is as follows. (wtχ) Invention product: Na)IcO: + 37.4. KHzP
Ot 60.6. Excipient 2.0 conventional product ■: NaHCO
z 42.0. NaHzPOa 56.0. Excipient 2
.. 0 Conventional product■: Na1lCO356,7, succinic acid
41.3. Excipient 2.0 conventional crystal ■: Na1CO326
, O+ NazSOa 35.0 Tartaric acid 37. O excipient 2.0 Table 1 Symbol A in the table: floats on the surface.
B:浴面近くで浮遊する。B: Floating near the bath surface.
C:浴湯中位〜上面に移動する。C: Move to the middle to upper surface of the bath.
D:浴場低位〜中位に移動する。D: Move to the lower to middle level of the bathhouse.
E:浴槽低部に沈降する。E: Sediments to the lower part of the bathtub.
表1の如く、従来品は相当の大型にしなければ浴槽底部
に沈まないに反し本発明品は1g以上であれば浴場内に
沈降するものである。この事は入浴時に数個投入出来る
から発泡源が多くなる利点がある一発泡浴剤が浴場の表
面に浮上する位置にあると、CO2ガスはいたずらに空
中へ放出するのであるから、浴用剤としての効果はない
のである。As shown in Table 1, the conventional product does not sink to the bottom of the bathtub unless it is of a considerable size, but the product of the present invention will settle in the bathtub if it weighs more than 1 g. This has the advantage of increasing the number of foaming sources because several foaming bath additives can be added when taking a bath.If the foaming bath additive is placed in a position where it floats to the surface of the bath, CO2 gas will be unnecessarily released into the air, so it cannot be used as a bath additive. There is no effect.
此の様に本発明品が浮上しないのは、その比重にも関係
するが発生炭酸ガスと離脱ガスのバランスにあると考え
られる。このことは瞬時に反応するのでなく、時間的に
均一に持続するためで、表1のブリケットを用い炭酸ガ
スの発生持続時間(分)を測定したところ表2の如くで
あった。The reason why the product of the present invention does not float is thought to be due to the balance between the carbon dioxide gas generated and the released gas, although it is also related to its specific gravity. This is because the reaction does not occur instantaneously, but continues uniformly over time. Table 2 shows the results of measuring the duration (minutes) of carbon dioxide gas generation using the briquettes shown in Table 1.
表2 次に、発泡浴用剤で問題となるのは経時的劣化である。Table 2 Next, a problem with foaming bath agents is their deterioration over time.
前述の様にアルカリ分と酸分薬品の混和薬剤であるから
、水分が介在するとき温度が高いとき反応が進み易い。As mentioned above, since it is a mixture of alkaline and acid chemicals, the reaction tends to proceed when moisture is present and the temperature is high.
従って製品は空中の湿分を受けない様にアルミ箔で密封
する如く配慮されるが、それでも必然的に使用場所が湿
分の高い浴室であるため、消費者はこの附近に在庫する
ので、包装の膨大・破裂事故の発生するケースがある。Therefore, care is taken to seal the product with aluminum foil to prevent it from getting exposed to moisture in the air, but even so, it is inevitably used in a bathroom with high humidity, so consumers stock it near this area, so packaging is difficult. There have been cases of large scale and rupture accidents.
また製品の運搬在庫で高温となった時、炭酸水素ナトリ
ウムは自己分解しH,0を放出するので、これが引金と
なって急速に(1)の反応を進行させるのである。この
比較実験は5.0gの前記ブリケットを用い各条件で実
験を行った結果を表3に示す。Furthermore, when the product is transported and stored at high temperatures, sodium hydrogen carbonate self-decomposes and releases H,0, which triggers the rapid progress of the reaction (1). This comparative experiment was conducted under various conditions using 5.0 g of the briquettes, and the results are shown in Table 3.
表3
表中の劣化度は(試験後のCO□発生盟/試験前のCO
2発生量) X100である。Table 3 The degree of deterioration in the table is (CO□ generation after test/CO before test
2 generation amount) X100.
次に問題となった点は、浴槽材料の変色に関する件であ
る。浴槽が樹脂やタイルでは変化はないが、ステンレス
やアルミニウム等金属では虹色の変色ないし著しいとき
は黒色斑点を生ずることが見受けられた。この原因を追
及してみると、浴槽底に沈んだ錠剤が溶解する際、その
接触面において高濃度溶液となるため、金属に作用する
影響が現れることが明らかとなった。The next problem was the discoloration of the bathtub material. If the bathtub is made of resin or tiles, there will be no change, but if the bathtub is made of metals such as stainless steel or aluminum, rainbow-colored discoloration or, in severe cases, black spots may be observed. When investigating the cause of this, it became clear that when the tablets that had sunk to the bottom of the bathtub melted, a highly concentrated solution formed at the contact surface, which had an effect on the metal.
この変色現象はとくに13Crl板に著しく、腐食に至
るわけでないが美観を損なうものである。この対策とし
て薬剤配合を種々検討した結果少なくとも溶液のpHが
4.5〜8.0の間であれば、現出しないことを確認し
た。こ\におけるPHの測定濃度は1.0g/ Loo
m lに溶解した液で行う。即ち通常の家庭用浴槽は1
801が標準であるから、0.12g/ 1であるが、
100倍濃度で行った方が明解である。This discoloration phenomenon is particularly noticeable on 13Crl plates, and although it does not lead to corrosion, it impairs the aesthetic appearance. As a countermeasure to this problem, we investigated various drug formulations and found that the drug does not appear if the pH of the solution is at least between 4.5 and 8.0. The measured concentration of PH in this place is 1.0g/Loo
This is carried out using a solution dissolved in ml. In other words, a normal household bathtub is 1
Since 801 is the standard, it is 0.12g/1, but
It is clearer if the concentration is 100 times higher.
なおこのPH範囲において、ブリケットとステンレス板
の接触面が変色する現象−ウォターステンレスーに関し
、本発明配合では生じないに反し、酒石酸配合品はとく
に変色が著しい現象がある。In this pH range, the phenomenon of discoloration of the contact surface between the briquette and the stainless steel plate (water stainless steel) does not occur with the formulation of the present invention, but the tartaric acid formulation exhibits a phenomenon in which the discoloration is particularly significant.
PRを4.5〜8.0におくことの意義は、常識の如く
考えられ勝ちであるが、浴槽に対する変色を絡んで重要
なことである。即ち前記〔1〕反応においてNa”−H
C0,−間は緩衝的反応であるので、完全な炭酸ガス発
生を期待するときは、理論的には5.8であるが実測し
てみると4.5以下である。従って多価無機物の第−塩
の配合を〔1〕の理論値より多くして目的が達せられる
が、この場合でも浴場中にて直ちに溶解すれば常水中の
他成分によってpHは4.5以上になり、浴槽材質に影
響はないけれども、タブレットとしたとき溶解を始める
ところは高濃度となるので影響が大きいのである。The significance of setting PR between 4.5 and 8.0 may be thought of as common sense, but it is important in relation to discoloration of bathtubs. That is, in the reaction [1] above, Na''-H
Since the reaction between C0 and - is a buffering reaction, when complete carbon dioxide gas generation is expected, the theoretical value is 5.8, but when actually measured, it is 4.5 or less. Therefore, the objective can be achieved by adding more salts of polyvalent inorganic substances than the theoretical value of [1], but even in this case, if it is immediately dissolved in the bath, the pH will be higher than 4.5 due to other components in the water. This does not affect the bathtub material, but when it is made into tablets, the concentration is high where it begins to dissolve, so it has a large effect.
よって配合は炭酸塩の方を理論値よりも多口がよく、こ
の際のPHはIg/ 100m l 濃度で、前記の4
,5〜8.0範囲とすべきことを確認したのである。Therefore, it is better to mix more carbonate than the theoretical value, and the pH at this time is Ig/100ml concentration, and the above 4.
, 5 to 8.0.
本R喝小よ甲釦酸性介にリン酸第−〃リウハ;リン政ニ
アに−1−カリウムKH2PO4Lを張6刊ゴるものl
二係りzカル′公灼のIノン勅蔓ニアg−ffgソ°7
ム’IN(lH2PO(tと近イL゛スして−・ろど左
えルトちC:あろが′、それ)七指潰険’C−M、実運
弊爽苑!二わ゛いで弱゛J己め如くBgら々\な喧1か
1石−j/−)うれるどころで・あう。This book R is small, the first button is acidic and the phosphoric acid is phosphoric acid.
2 people in charge z cal' public burnt I non-order near g-ffg so°7
M'IN(lH2PO(t and close to L)-・Rod left hand C: Aroga', that) Seven-finger crushing'C-M, real luck and trouble!Two-way Weak ゛J As if I were Bg ra \ na 1 or 1 koku -j/-) I'm so happy that I'm so happy.
(実施例)
実施例2
乾燥硫酸ナトリウム 12.0 重量部塩化ナト
リウム io、o 〃炭酸水素ナトリウム
29.0 〃リン酸二水素カリウム 46
.4 〃オウバクエキス 0.1〃
香料 0.5〃
乳糖 2.0〃
着色料 微量 〃
エタノール 1.5〃
合計 101.5
前記を混合し1個50gのマセフク型に圧縮成型し、本
発明品を得た。P旧ま6.81本発明品を浴場に投入し
たとき約8分間、浴場の表面に浮上することなく、浴場
底部より発泡しつつ溶解した
ウォーターステン現象は認められなかった。(Example) Example 2 Dry sodium sulfate 12.0 parts by weight Sodium chloride io, o Sodium hydrogen carbonate 29.0 Potassium dihydrogen phosphate 46
.. 4. Arum extract 0.1. Flavoring 0.5. Lactose 2.0. Coloring agent trace amount. Ethanol 1.5. Total 101.5. The above was mixed and compression molded into massifuku molds each weighing 50 g to obtain the product of the present invention. Obtained. 6.81 When the product of the present invention was placed in a bath, it did not rise to the surface of the bath for about 8 minutes, and no water stain phenomenon was observed, in which the product bubbled and dissolved from the bottom of the bath.
実施例3
無水炭酸カリウム・ナトリウム43 重量部リン酸二
水素カリウム 30
多硫化カリウム 5 〃炭酸マグネシ
ウム lO〃
酸性硫酸ナトリウム 2 〃第一ホウ酸ナ
トリウム 5 〃でんぷん
3 〃ポリエチレングリコール 2
〃合計 100
を混合し、1個20gに成型し、本発明品を得た。Example 3 Anhydrous potassium carbonate/sodium 43 Part by weight Potassium dihydrogen phosphate 30 Potassium polysulfide 5 Magnesium carbonate 1O Sodium acid sulfate 2 Sodium primary borate 5 Starch
3 Polyethylene glycol 2
A total of 100 pieces were mixed and molded into 20g pieces to obtain a product of the present invention.
PHは7.2.である。本浴用剤は炭酸ガスの発生と共
に、浴場はコロイド硫黄が析出し白濁し天然温泉気分を
満喫できる。PH is 7.2. It is. This bath agent generates carbon dioxide gas, and colloidal sulfur precipitates in the bath, making it cloudy and allowing you to enjoy the feeling of a natural hot spring.
(発明の効果)
■、炭酸ガス発泡型浴用剤において、従来の有機酸配合
品より本発明品は、浴用有効成分の多いものが得られる
。(Effects of the Invention) (1) Among carbon dioxide foaming bath additives, the products of the present invention contain more active ingredients for bathing than conventional products containing organic acids.
2、従来の炭酸ガス発泡浴用剤よりも、安定した持続時
間の長い炭酸ガスの発生が認められる。2. It is observed that carbon dioxide gas is generated more stably and for a longer time than conventional carbon dioxide foaming bath agents.
3、本発明品は浴槽底に沈み、場面に浮上して炭酸ガス
の無効放出がない。3. The product of the present invention sinks to the bottom of the bathtub and rises to the surface, so there is no ineffective release of carbon dioxide gas.
4、吸湿性が少く、経時変化に耐え得る。4. Has low hygroscopicity and can withstand changes over time.
5、金属材料の変色腐食が避けられる。5. Discoloration and corrosion of metal materials can be avoided.
以上that's all
Claims (1)
炭酸塩、重炭酸塩の一種または二種以上と、リン酸二水
素カリウムと、更に必要なときは他の浴用成分ならびに
賦型剤、吸湿防止剤、香料、色素とを配合し、その配合
物を1個が1.0g以上のタブレットに成型し、その1
gを100mlの水に溶解したときのPHが4.5〜8
.0であることを特徴とする浴用剤。One or more carbonates, sesquicarbonates, and bicarbonates of alkali metals or alkaline earth metals, potassium dihydrogen phosphate, and, if necessary, other bath components, excipients, and moisture absorption inhibitors. , fragrance, and pigment, and mold the mixture into tablets each weighing 1.0 g or more.
PH is 4.5-8 when g is dissolved in 100ml of water.
.. A bathing agent characterized by having a concentration of 0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8551387A JPS63250316A (en) | 1987-04-07 | 1987-04-07 | Bathing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8551387A JPS63250316A (en) | 1987-04-07 | 1987-04-07 | Bathing agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63250316A true JPS63250316A (en) | 1988-10-18 |
Family
ID=13860998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8551387A Pending JPS63250316A (en) | 1987-04-07 | 1987-04-07 | Bathing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63250316A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336367A (en) * | 1991-10-31 | 1994-08-09 | Matsushita Electric Industrial Co. Ltd. | Solid-state imaging device and method of manufacturing the same |
-
1987
- 1987-04-07 JP JP8551387A patent/JPS63250316A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336367A (en) * | 1991-10-31 | 1994-08-09 | Matsushita Electric Industrial Co. Ltd. | Solid-state imaging device and method of manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5970610A (en) | Foaming bathing agent | |
Richold | Boron exposure from consumer products | |
GB2527625A (en) | Composition | |
US5015643A (en) | Disinfectant for the treatment of water systems | |
KR960009645B1 (en) | Weakly acidic bath agents | |
JPH04100900A (en) | Composite solid material and production thereof | |
JPS63250316A (en) | Bathing agent | |
RU2667641C2 (en) | Detergent composition | |
US3576644A (en) | Dry alcoholic beverage forming compound | |
JPH02324B2 (en) | ||
JPS59106415A (en) | Bathing agent | |
JPH01254619A (en) | Bathing agent | |
JPS63258806A (en) | Bathing agent and production thereof | |
JPH08325137A (en) | Bathing agent | |
JPS6245516A (en) | Foamable bathing agent | |
JPS5566507A (en) | Preparation of foamed tablet | |
JP2841517B2 (en) | Bath additive | |
EP0150250B1 (en) | Gas-emitting bath additive composition | |
JPS59227999A (en) | Creamy detergent | |
JPS61243014A (en) | Foaming bath agent | |
CA1134708A (en) | Bath salt | |
JPS63284120A (en) | Preparation for bathing | |
KR20160129449A (en) | Cleansing agent for an artificial tooth | |
JPS632935B2 (en) | ||
JPS6216409A (en) | Beautifying agent containing sodium chloride |